Prolia Injection
Product Images NDC 55513-710
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Prolia (NDC 55513-710). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Step 1: Remove Grey Needle Cap (Prolia 02)
Choose An Injection Site. The Recommended Injection Sites For Prolia Include: The Upper Arm Or The Upper Thigh Or The Abdomen. (Prolia 03)
Insert Needle And Inject All The Liquid Subcutaneously. Do Not Administer Into Muscle Or Blood Vessel. (Prolia 04)
Hold Clear Finger Grip. (Prolia 05)
Gently Slide Green Safety Guard Over Needle And Lock Securely In Place. Do Not Grip Green Safety Guard Too Firmly When Sliding Over Needle. (Prolia 06)
Figure 1. Cumulative Incidence Of Hip Fractures Over 3 Years (Prolia 07)
Prolia 08
Principal Display Panel1 X 60 mg Single Use Prefilled Syringendc 55513-710-01amgen®prolia®(denosumab)60 mg/ml60 mg/ml Injection – For Subcutaneous Use Only.single Use Prefilled Syringe. Discard Unused Portion.sterile Solution – No Preservative.rx Onlyrefrigerate At 2° To 8°c (36° To 46°f). Do Not Freeze. Avoid Excessive Shaking. Protect From Direct Light And Heat.this Product Contains Dry Natural Rubber.manufactured By: Amgen Inc., Thousand Oaks, Ca 91320-1799 (Prolia 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.